Financial Snapshot

Revenue
$64.27M
TTM
Gross Margin
60.92%
TTM
Net Earnings
-$70.37M
TTM
Current Assets
Q3 2023
Current Liabilities
Q3 2023
Current Ratio
8.03%
Q3 2023
Total Assets
Q3 2023
Total Liabilities
Q3 2023
Book Value
-$250.2M
Q3 2023
Cash
Q3 2023
P/E
-0.007807
Sep 13, 2024 EST
Free Cash Flow
-$32.02M
TTM

Revenues

Revenues

Revenue YoY Change

Revenues

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Interest Expenses

Interest Expenses To Operating Income %

No data

Other Expense/Income

Interest & Other Expense/Income

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

No data

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

No data

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

No data

Treasury Stock Shares

No data

Stock Issuance & Repurchase

Ownership Data

Concept 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Dividends

No data

Stock Price

Market Cap: $549.43 Thousand

About NantHealth, Inc.

NantHealth, Inc. engages in the provision of enterprise solutions that help businesses transform complex data into actionable insights. The company is headquartered in Morrisville, North Carolina and currently employs 364 full-time employees. The company went IPO on 2016-06-02. The firm is engaged in offering ways to move, interpret, and visualize complex and highly sensitive information to its customers in the healthcare, life sciences, logistics, telecommunications, and other industries to automate, understand, and act on data while keeping it secure and scalable. The Company’s products include Eviti Connect and Eviti Advisor, NaviNet, NaviNet Open, NaviNet AllPayer, OpenNMS, and Quadris. Its product portfolio comprises the technology in payer/provider collaboration platforms for real-time coverage decision support (Eviti and NaviNet) and data solutions that include multi-data analysis, reporting, and professional service offerings (Quadris). In addition, The OpenNMS Group, Inc. (OpenNMS), a Company’s subsidiary, helps businesses monitor and manage network health and performance.

Industry: Services-Computer Processing & Data Preparation Peers: Better Therapeutics, Inc. BIOTRICITY INC. MediXall Group, Inc. HealthLynked Corp ICAD INC iSpecimen Inc.